ro 32-3555 has been researched along with ym 60828 in 1 studies
| Studies (ro 32-3555) | Trials (ro 32-3555) | Recent Studies (post-2010) (ro 32-3555) | Studies (ym 60828) | Trials (ym 60828) | Recent Studies (post-2010) (ym 60828) |
|---|---|---|---|---|---|
| 15 | 1 | 4 | 27 | 0 | 2 |
| Protein | Taxonomy | ro 32-3555 (IC50) | ym 60828 (IC50) |
|---|---|---|---|
| Coagulation factor X | Mus musculus (house mouse) | 0.006 | |
| Prothrombin | Homo sapiens (human) | 0.0077 | |
| Coagulation factor X | Homo sapiens (human) | 0.002 | |
| Anionic trypsin-2 | Rattus norvegicus (Norway rat) | 0.063 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for ro 32-3555 and ym 60828
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |